Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.

Dawoud M, Al-Husseiny M, Helal O, Elsherbini M, Abdel-Rasheed M, Sediek M

Open source

DOI
10.1186/s12884-023-05935-5
Published
2023 Aug 25
Container
BMC pregnancy and childbirth
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 27/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12884-023-05935-5,
  title = {Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.},
  author = {Dawoud M and Al-Husseiny M and Helal O and Elsherbini M and Abdel-Rasheed M and Sediek M},
  year = {2023},
  journal = {BMC pregnancy and childbirth},
  doi = {10.1186/s12884-023-05935-5},
  url = {https://doi.org/10.1186/s12884-023-05935-5}
}

RIS

TY  - JOUR
TI  - Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.
AU  - Dawoud M
AU  - Al-Husseiny M
AU  - Helal O
AU  - Elsherbini M
AU  - Abdel-Rasheed M
AU  - Sediek M
PY  - 2023
JO  - BMC pregnancy and childbirth
DO  - 10.1186/s12884-023-05935-5
UR  - https://doi.org/10.1186/s12884-023-05935-5
ER  - 

APA

M, D., M, A., O, H., M, E., M, A., & M, S. (2023). Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.. BMC pregnancy and childbirth. https://doi.org/10.1186/s12884-023-05935-5

Source records